Scancell Share Discussion Threads

[inanaco] 24/9/2023 13:46

well you have been here long enough for intelligence to pick up the science Ruck

and even simple accounting ..........

all you have done is show us that you suffer episodes of depression and your ability to bear a grudge exceeds Putin .....

while blaming everyone else for you being stuck in the share ............

even after you posted ......... "scancell will never make a return"

so if you now think you are intelligent ...

act like it

[ruckrover] 24/9/2023 13:42

Inan, Don't confuse slow as in doing other stuff with slow as in engaging brain cells.

[ruckrover] 24/9/2023 13:40

On the Scancell science, not intelligence wise.

[inanaco] 24/9/2023 13:32

Hey Ruck just a reminder about "slow people"


you admitted to being "inferior" to Bermuda and Ray .....

😉

[inanaco] 24/9/2023 13:11

seems Lozan and MT are combining forces .... how wonderful for MT ....🥳

[the real lozan] 24/9/2023 13:07

METT -
Perhaps Lindy could look into developing a vaccine to combat METT .........
( Mental EGOdriven trHYPE Transmission ) that appears to be out of CONtrol

[inanaco] 24/9/2023 13:03

Nigel did ...... miscellaneous items 👏

[inanaco] 24/9/2023 13:00

well we know you are Ruck ... did you find the ip on the balance sheet .... ? 🤣🤣🤣🤣

[nigelpm] 24/9/2023 12:59

I think that was precisely MT's point Ruck ;-)

[ruckrover] 24/9/2023 12:55

MT, "If I were to post (as a reasonable rough guess) that 90% of posts on here are from people who would be classified as "very slow learners""Well 90% of posts are from Inan and Marcus so are you saying they are the only slow learners?

[inanaco] 24/9/2023 12:53

MarkingTime - 19 Sep 2023 - 12:11:53 - 5915 of 6222 Scancell - Pot of Gold or POS? - SCLP
There is a steady transfer from weak hands to strong hands going on. Finally this is the week when funds finally start to take serious interest and relieve many amateurs of their holdings. Don't expect any holdings announcements for a few weeks yet though...


amateurs see risk ?

🤦‍a94;️

[inanaco] 24/9/2023 12:50

so which is it MT .....

Risky to hold

Risky to buy

Carries Risk (but don't know what)

and how does all that apply to

very large bid premium, especially from a baseline share price that is even more "derisory" than it was six months ago

😎

[inanaco] 24/9/2023 12:41

MT posts Firesales never make top prices ............

clearly has never been to an auction ....... £100m art can sell in mins ....

but forgets his own posts ........



MarkingTime - 20 Sep 2023 - 08:56:31 - 5958 of 6220 Scancell - Pot of Gold or POS? - SCLP
One other aspect of BMS etc....
BMS may have a particular interest in SCIB1, but a whole company deal might enable them to develop new revenue streams that might otherwise accrue to other major pharmas. So taking everything may strengthen a company's competitive position versus other major pharmas.
To me, that indicates a very large bid premium, especially from a baseline share price that is even more "derisory" than it was six months ago.


Bid premium is that not auction talk ....
🤦‍a94;️

[inanaco] 24/9/2023 12:22

Tf that is not in the clinic atb

[inanaco] 24/9/2023 12:21

not once could anybody answer

which one has failed

SCIB1

or

Keytruda

those describing risk could never answer that post ...........

🤷‍a94;️

[inanaco] 24/9/2023 12:17

two share holders

one walks around knowing they have it right on SCIB1 so builds a 1.4m holding its all in my history no risk applies to scib1

the other is convinced its risky so only invests a punt ...

Scancell trial outcome is the same to both ....

except one holder is happy

the other is a nervous investor .

👌 i got it right

PS Colin from accounts sold before news 😢😢😢😢8546;😢ԅ46;😢😢;😢😢😢😢
28546;😢€546;😢

[marcusl2] 24/9/2023 10:38

iSC2811 enhances T cell engraftment and prevents exhaustion
Potential for improving CAR-T approaches

[marcusl2] 24/9/2023 10:34

nomlungu

‘Without reductive carboxylation, the cells no longer differentiate as much and maintain their anti-tumor function for longer. And even, and this is the heart of our discovery, they tend to transform into memory T lymphocytes, a type of immune cell that retains the memory of the tumour elements that needs to be attacked,’’

[ivyspivey] 24/9/2023 10:04

Agree Nigel,
Any Company which has revenues and profit is much more easier to attract an accurate valuation even in administration as you can apply conventional metrics.
Many don’t accept the conventional ways of measuring pre revenue Companys like SCLP such as risk adjusted DCF employed by likes of TD.
So if you don’t accept thst or current market cap but are relying on uninformed opinion then you may as well put your finger in the wind.
The only certain value whether in admin or not is what someone is willing to pay and with no realistic peer evaluation it is pure guesswork largely based on what people perceive as the value so dreams vs reality

[markingtime] 24/9/2023 10:02

If I were to post (as a reasonable rough guess) that 90% of posts on here are from people who would be classified as "very slow learners", then I guarantee that everyone would say "fair enough, because I'm in the 10%".............thereby proving the point.These are not difficult concepts:1. Equity risk is never zero2. Firesales never make top prices3. Research has some (possibly substantial) hope value, but it is not yet "an asset", let alone one which can (or should!) appear in a balance sheet with a fixed figure against it as "fair value".

[nigelpm] 24/9/2023 08:24

Correct inanco but they make revenues and profits and can easily tap the debt markers for cash so we are not talking about needing to go to a firesale for the major pharmas.

[marcusl2] 24/9/2023 07:46

SCIB2 is the second cancer vaccine based on the ImmunoBody® technology and encodes a modified antibody engineered to express multiple epitopes from the cancer antigen NY-ESO-1. This is a well-characterised and validated cancer target, being overexpressed in several tumour types including synovial sarcomas, oesophageal, liver, gastric, prostate and lung cancers.

The Fc region of SCIB2 has also been modified using the AvidiMab® technology to generate the iSCIB2 product. This modification will enhance the Fc targeting of the iSCIB2 ImmunoBody® to dendritic cells and induce higher frequency T cell responses.

The SCIB2/iSCIB2 vaccine is under evaluation for the treatment of patients with solid tumours, including non-small cell lung cancer (NSCLC).

[inanaco] 24/9/2023 05:31

To give you an example, think about a pharmaceutical company. The factory in which the medicines are produced is a tangible asset, whereas the chemical formulae of the medicines, the patents, the permission to make the drugs (the manufacturing licence) and the brand are all intangible assets.


Google

near impossible to get a valuation that is accredited

however if you bought them, its possible to list them as intangible

but they could also be hidden in cost of sales ..

Scancell accounts show no "intangible assets"

so is not accounting for the value of any patent in this form

because it does not need to !!!!!

Hope that helps

ASSETS
Non-current assets
Tangible fixed assets 9 1,579 692
Right-of-use assets 10 1,165 283
Goodwill 11 3,415 3,415
6,159 4,390

[golcheja] 24/9/2023 00:52

It looks that CW is only posting links but refrain from stating his opinion as to what he think re SC…. As if it is important.

Well it not important , actually it’s pile of nonsense better spend my valuable time watching murder she wrote. Take a break CW and embark on a very long vacation.